Awareness, treatment, control, and determinants of dyslipidemia among adults in China

Abstract

Effective management of dyslipidemia is important. This study aimed to determine the awareness, treatment, control, and determinants of dyslipidemia in middle-aged and older Chinese adults in China. Using data from the 2015 China National Stroke Screening and Prevention Project (CNSSPP), a nationally representative sample of 135,403 Chinese adults aged 40 years or more were included in this analysis. Dyslipidemia was defined by the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults final report (NCEP-ATP III) and the 2016 Chinese guidelines for the management of dyslipidemia in adults. Models were constructed to adjust for subjects’ characteristics with bivariate and multivariable logistic regression analyses. Overall, 51.1% of the subjects were women. Sixty-four percent were aware of their condition, of whom 18.9% received treatment, and of whom 7.2% had adequately controlled dyslipidemia. Dyslipidemia treatment was higher in men from rural areas than their urban counterparts. The multivariable logistic regression models revealed that women, urban residents, and general obesity were positively related to awareness. Women, married respondents, and current drinkers had higher odds of treatment. Age group, overweight, general obesity, urban residence, and women were independent determinants of control. Dyslipidemia awareness rate was moderately high, but treatment and control rates were low. Results can be used to develop policies and health promotion strategies with special focus on middle-aged and older adults.

Effects of Body Mass Index, Waist Circumference, Waist-to-Height Ratio and Their Changes on Risks of Dyslipidemia among Chinese Adults: The Guizhou Population Health Cohort Study

“…CVD has been the leading cause of death worldwide [ 4 ] and accounted for 45.50% and 43.16% of all deaths in rural and urban areas of China in 2016, respectively [ 5 ]. Of note, weak awareness and management of dyslipidemia were reported among Chinese adults [ 6 ]. In recent years, the prevalence of dyslipidemia among the general population of China has continuously increased [ 7 ], although previous studies indicated that early screening and effective control of dyslipidemia may help to reduce the morbidity and mortality due to CVD [ 8 , 9 ].…”

Trends of Hypercholesterolemia Change in Shenzhen, China During 1997–2018

“…This may also be relevant to sex differences in awareness, treatment, and self-management. A previous study found that women were more aware of dyslipidemia, more likely to receive treatments for it, and more likely to have their condition controlled compared with men ( 22 ). However, the higher prevalence of hypercholesterolemia and low HDL-C in women than in men in the age group of 40–59 years should be noted.…”

Landscape of cardiometabolic risk factors in Chinese population: a narrative review

“…The nationwide study InterASIA in 2000–2001 provided the first glimpse into the prevalence of dyslipidemia in China, which found that 53.6% of adults aged 35–74 years had dyslipidemia, and in regard to its components, 9.0%, 5.1%, and 19.2% had high total cholesterol, high low-density lipoprotein cholesterol (LDL-C), and low high-density lipoprotein cholesterol (HDL-C), respectively [ 7 , 41 ]. Studies in 2014–2019 revealed a consistently high prevalence of dyslipidemia in China, ranging from 33.8 to 43% among adults of middle or senior ages; presentations with high triglycerides (16.9–22.4%) and low HDL-C (15.6–19.9%) were more common compared with high total cholesterol (7.1%–11.3%) and high LDL-C (4.0–8.1%) [ 42 – 44 ]. Among adults aged ≥ 18 years, the prevalence of high total cholesterol, high triglycerides, high LDL-C, and low HDL-C was reported to be 6.9%, 13.8%, 8.1%, and 20.4% in 2013–2014, respectively [ 45 ].…”